Biological Information

Background Information:

The Path Hunter mFcyRIIb clustering cell line is a stable, engineered cell line designed to increase signal produced from a Checkpoint Cell Line via antibody-mediated crosslinking of the receptors. This product is a companion product used to determine cross-linking based increases in potency of agonist antibodies. The cell line included overexpresses mFcyRIIb Fcg receptor. When co-cultured with a Checkpoint Cell Line in the presence of agonist antibody, the Fcg receptor binds to the antibody, inducing receptor clustering. The induced receptor clustering leads to increased activation and downstream signaling, leading to increased EFC signal production.
This stable engineered cell line is provided as two vials of cryopreserved cells. Please note that this product expresses the Mouse version of this protein.

Target Class:

Checkpoint Receptor

Family:

IgSF

Sub Family:

Immunoglobulin Fc Receptor

Protein Name:

FcgR2B

Protein Aliases:

Fc gamma receptor IIB (Fc-gamma RII|Fc-gamma-RIIB| FcRII)|IgG Fc receptor II beta|Lymphocyte antigen 17 (Ly-17)|CD32

Accession Number:

NM_001077189.1

UniProt Number:

P08101

Gene Name:

Fcgr2b

Gene ID:

14130

Gene Aliases:

CD32|Fcgr2|Fcr-2|Fcr-3|Ly-17|LyM-1|Lym-1|fcRII|FcgRII|Fcgr2a|Ly-m20|Fc[g]RII|F630109E10Rik

Target Species:

Mouse

Cell Background:

U2OS

Usage

Product Type:

Stable Cell Lines

Application:

Drug Discovery & Development

Storage Conditions:

Store in vapor phase of liquid nitrogen.

Usage disclaimer:

These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Assay Information

Assay Type:

Cell Based

Assay Measures:

Clustering

Detection Method:

Chemiluminescence

Clinical Relevance

Therapeutic Area:

Oncology/Immuno-Oncology

Additional Information

Brand:

PathHunter®